Gland Pharma Limited (GLAND)

Volume: 25,619Avg Vol 1W: 1,93,997Avg Vol 1M: 3,10,85252W Range:₹1,573.6₹2,396

₹2,197.6▲ 0.87%

Key Ratios

Market Cap₹37,299 Cr

Current Price₹2,197.6

Previous Close₹2,178.7

High / Low (52w)₹2,396 / ₹1,573.6

Volume25,619

Avg Vol (1W)1,93,997

Avg Vol (1M)3,10,852

Stock P/E37.55

Book Value₹628.52

Dividend Yield0.88%

ROE9.92%

ROA8.21%

Revenue (TTM)—

Revenue Growth-0.85%

Profit Margin15.98%

Total Debt₹78 Cr

Shares Outstanding16 Cr

Face Value₹1

EPS (TTM)₹22.26

P/B3.05

Debt / Equity0.03

50 DMA₹2,198.08

200 DMA₹1,867.83

Day change+0.87%

Price Chart

₹2,197.6▲ 14.16% · 1Y

2025-10-20

2026-06-16

20-day avg volume: 3.1L shares

Pros

Quarterly Results

Metric	Mar 2026	Dec 2025	Sept 2025	Jun 2025	Mar 2025	Dec 2024	Sept 2024	Jun 2024	Mar 2024	Dec 2023	Sept 2023	Jun 2023	Mar 2023	Dec 2022	Sept 2022	Jun 2022	Mar 2022	Dec 2021	Sept 2021	Jun 2021	Mar 2021	Dec 2020	Sept 2020	Jun 2020	Mar 2020
Revenue	₹1,743 Cr	₹1,695 Cr	₹1,487 Cr	₹1,506 Cr	₹1,425 Cr	₹1,384 Cr	₹1,406 Cr	₹1,402 Cr	₹1,537 Cr	₹1,545 Cr	₹1,373 Cr	₹1,209 Cr	₹785 Cr	₹938 Cr	₹1,044 Cr	₹857 Cr	₹1,103 Cr	₹1,063 Cr	₹1,080 Cr	₹1,154 Cr	₹888 Cr	₹859 Cr	₹832 Cr	₹884 Cr	₹635 Cr
EBITDA	₹516 Cr	₹390 Cr	₹292 Cr	₹324 Cr	₹296 Cr	₹322 Cr	₹263 Cr	₹224 Cr	₹308 Cr	₹288 Cr	₹296 Cr	₹266 Cr	₹170 Cr	₹313 Cr	₹326 Cr	₹309 Cr	₹383 Cr	₹367 Cr	₹402 Cr	₹473 Cr	₹350 Cr	₹274 Cr	₹293 Cr	₹420 Cr	₹262 Cr
Net Profit	₹367 Cr	₹261 Cr	₹184 Cr	₹215 Cr	₹187 Cr	₹205 Cr	₹164 Cr	₹144 Cr	₹192 Cr	₹192 Cr	₹194 Cr	₹194 Cr	₹79 Cr	₹232 Cr	₹241 Cr	₹229 Cr	₹286 Cr	₹273 Cr	₹302 Cr	₹351 Cr	₹260 Cr	₹204 Cr	₹219 Cr	₹314 Cr	₹195 Cr
EPS	22.23	15.87	11.15	13.08	11.32	12.42	9.93	8.73	11.68	11.65	11.78	11.78	4.78	14.08	14.65	13.92	17.36	16.62	18.37	21.37	15.88	12.82	14.12	20.24	12.57

Profit & Loss (Annual)

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Revenue	₹5,830 Cr	₹5,835 Cr	₹3,865 Cr	₹4,625 Cr	₹3,598 Cr	₹2,772 Cr
EBITDA	₹1,105 Cr	₹1,159 Cr	₹1,118 Cr	₹1,624 Cr	₹1,338 Cr	₹1,000 Cr
Net Profit	₹699 Cr	₹772 Cr	₹781 Cr	₹1,212 Cr	₹997 Cr	₹773 Cr
EPS	42.4	46.89	47.43	73.64	62.99	49.88

Balance Sheet

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Total Assets	₹11,225 Cr	₹10,661 Cr	₹8,778 Cr	₹7,834 Cr	₹6,496 Cr	₹4,086 Cr
Total Liabilities	₹2,074 Cr	₹1,937 Cr	₹819 Cr	₹676 Cr	₹593 Cr	₹440 Cr
Equity	₹9,151 Cr	₹8,724 Cr	₹7,959 Cr	₹7,158 Cr	₹5,903 Cr	₹3,646 Cr
Total Debt	₹78 Cr	₹107 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹4 Cr

Cash Flow

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Operating	₹1,269 Cr	₹1,303 Cr	₹675 Cr	₹1,197 Cr	₹916 Cr	₹945 Cr
Investing	₹1,705 Cr	₹-1,757 Cr	₹1,208 Cr	₹-1,003 Cr	₹-1,524 Cr	₹-766 Cr
Financing	₹-433 Cr	₹-799 Cr	₹15 Cr	₹35 Cr	₹1,238 Cr	₹-7 Cr
Free Cash Flow	₹1,269 Cr	₹1,303 Cr	₹675 Cr	₹1,197 Cr	₹916 Cr	₹945 Cr

Shareholding

Promoter 51.83% Institutions 40.65% Public 7.52%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search